Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(414)
Pinuccia Valagussa
19
Jose Baselga (José Baselga)
18
Giuseppe Capri
16
Cristiana Sessa
13
Milvia Zambetti
12
Journals
(30)
EUR J CANCER
16
EJC SUPPL
15
ANN ONCOL
9
J CLIN ONCOL
9
BREAST CANCER RES TREAT
5
Keywords
(166)
Embed
Subscribe
Academic
Authors
Luca Gianni
Luca Gianni,Istituto Nazionale Ricerca Cancer,Oncology,Anatomy,Pharmacology
Edit
Luca Gianni
Istituto Nazionale Ricerca Cancer
Publications:
96
|
Citations:
2028
Fields:
Oncology
,
Anatomy
,
Pharmacology
View FAQ about top research areas and Fields of study
Collaborated with
414 co-authors
from 1983 to 2011
|
Cited by
6411 authors
Cumulative
Annual
Sort by:
Publications
(96)
BibTeX
|
RIS
|
RefWorks
Download
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
(
Citations: 5
)
Luca Gianni
,
Urania Dafni
,
Richard D Gelber
,
Evandro Azambuja
,
Susanne Muehlbauer
,
Aron Goldhirsch
,
Michael Untch
,
Ian Smith
,
José Baselga
,
Christian Jackisch
,
David Cameron
,
Max Mano
http://academic.research.microsoft.com/io.ashx?type=5&id=49598096&selfId1=21217813&selfId2=0&maxNumber=12&query=
Journal:
Lancet Oncology - LANCET ONCOL
, vol. 12, no. 3, pp. 236-244, 2011
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
(
Citations: 1
)
Angelica Fasolo
,
Veronique Dieras
,
Fatima Cardoso
,
Jonas Bergh
,
Luc Vittori
,
Yufen Zhang
,
Cristian Massacesi
,
Tarek Sahmoud
,
Luca Gianni
Journal:
Breast Cancer Research and Treatment - BREAST CANCER RES TREAT
, vol. 125, no. 2, pp. 447-455, 2011
A Double-blind, Randomized Phase lib Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared to Placebo (PL) When Administered in Combination with Docetaxel And/or Letrozole in Patients with Metastatic Breast Cancer (MBC): FMB07-01 Trial
G. Mariani
,
O. Burdaeva
,
L. Roman
,
E. Staroslawska
,
D. Udovitsa
,
P. Driol
,
G. Goisis
,
C. Zamagni
,
V. Semiglazov
,
L. Gianni
Journal:
European Journal of Cancer - EUR J CANCER
, vol. 47, pp. 10-10, 2011
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study
V. Semiglazov
,
W. Eiermann
,
M. Zambetti
,
A. Manikhas
,
A. Bozhok
,
A. Lluch
,
S. Tjulandin
,
M. D. Sabadell
,
A. Caballero
,
P. Valagussa
,
J. Baselga
,
L. Gianni
Journal:
Ejso
, vol. 37, no. 10, pp. 856-863, 2011
1257 POSTER Phase I Safety and Tolerability Study of Olaparib (AZD2281) in Combination With Liposomal Doxorubicin (PLD) in Patients With Advanced Metastatic Solid Tumours
C. Sessa
,
R. von Moos
,
T. Digena
,
G. Del Conte
,
L. Viganö
,
E. Gallerani
,
R. Cathomas
,
A. Fasolo
,
D. Schneider
,
L. Gianni
Journal:
European Journal of Cancer - EUR J CANCER
, vol. 47, pp. S161-S162, 2011
Sort by:
Citations
(2028 times by 1611 publications)
CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules
Ji-Hyun Lee
,
Dae Gyu Kim
,
Tae Jeong Bae
,
Kyoohyoung Rho
,
Ji-Tae Kim
,
Jong-Jun Lee
,
Yeongjun Jang
,
Byung Cheol Kim
,
Kyoung Mii Park
,
Sunghoon Kim
Journal:
PLOS One
, vol. 7, no. 8, 2012
ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers
Paola D. Vermeer
,
Megan Bell
,
Kimberly Lee
,
Daniel W. Vermeer
,
Byrant G. Wieking
,
Erhan Bilal
,
Gyan Bhanot
,
Ronny I. Drapkin
,
Shridar Ganesan
,
Aloysius J. Klingelhutz
,
Wiljan J. Hendriks
,
John H. Lee
Journal:
PLOS One
, vol. 7, no. 1, 2012
Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer
Alexandre Ho-Pun-Cheung
,
Hervé Bazin
,
Nadège Gaborit
,
Christel Larbouret
,
Patrick Garnero
,
Eric Assenat
,
Florence Castan
,
Caroline Bascoul-Mollevi
,
Jeanne Ramos
,
Marc Ychou
,
André Pèlegrin
,
Gérard Mathis
http://academic.research.microsoft.com/io.ashx?type=5&id=57406421&selfId1=21217813&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 7, 2012
N-Cadherin in Neuroblastoma Disease: Expression and Clinical Significance
Tim Lammens
,
Katrien Swerts
,
Lara Derycke
,
Annemie De Craemer
,
Sara De Brouwer
,
Katleen De Preter
,
Nadine Van Roy
,
Jo Vandesompele
,
Frank Speleman
,
Jan Philippé
,
Yves Benoit
,
Klaus Beiske
http://academic.research.microsoft.com/io.ashx?type=5&id=57402692&selfId1=21217813&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 2, 2012
Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2Positive Metastatic Breast Cancer
Sae-Won Han
,
Yongjun Cha
,
Agnes Paquet
,
Weidong Huang
,
Jodi Weidler
,
Yolanda Lie
,
Thomas Sherwood
,
Michael Bates
,
Mojgan Haddad
,
In Hae Park
,
Do-Youn Oh
,
Keun Seok Lee
http://academic.research.microsoft.com/io.ashx?type=5&id=57406631&selfId1=21217813&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 7, 2012
Comments